Tasso
Techstars '17Seattle, US · Founded 2018 · Delaware corporation · 6 known investors
Tasso develops diagnostic testing devices and platforms for home use, enabling patients to perform health monitoring and inform clinical decisions outside traditional healthcare settings.
Founders & leadership
BC
Ben CasavantCo-Founder and Chief Executive Officer
EB
Erwin BerthierCo-Founder and Chief Technology Officer
EH
Elizabeth HambrechtDirector
AL
Alan LevyDirector
PC
Paul ConleyDirector
Investors · 6
Reported raises · per SEC filings
Form D private placements▶$17MraisedJul 2020 · 9 investors · OtherRule 506(b)
▶$17MraisedJul 2020 · 9 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Elizabeth HambrechtDirector
- Ben CasavantExecutive Officer, Director, Promoter
- Alan LevyDirector
- Paul ConleyDirector
- Erwin BerthierExecutive Officer, Director, Promoter
- Offering amount
- $17M
- Amount sold
- $17M
- Minimum investment
- $1
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Tasso, Found score $100M and more digital health fundings | MobiHealthNewsmobihealthnews.com · 2021
- Tasso, Maker Of Home Blood-Draw Kits, Raises $100 Million Led By RA Capitalforbes.com · 2021
- Tasso secures $100M in Series B financing — Tasso, Inc.tassoinc.com · 2021
- Tasso Raises $17M in Series A Financing - FinSMEsfinsmes.com · 2020
- Tasso raises $17 million for home blood-testing kits | VentureBeatventurebeat.com · 2020